|
|
| Line 1: |
Line 1: |
| {{drugbox
| |
| | IUPAC_name = 2,2'-[(1,4-dioxobutane-1,4-diyl)bis(oxy)]bis<br>(''N'',''N'',''N''-trimethylethanaminium)
| |
| | image = Suxamethonium-chloride-2D-skeletal.svg
| |
| | CAS_number = 306-40-1
| |
| | ATC_prefix = M03
| |
| | ATC_suffix = AB01
| |
| | ATC_supplemental =
| |
| | PubChem = 5314
| |
| | DrugBank = APRD00159
| |
| | C = 14 | H = 30 | N = 2 | O = 4
| |
| | molecular_weight = 290.399 g/mol
| |
| | bioavailability = NA
| |
| | protein_bound =
| |
| | metabolism = By [[pseudocholinesterase]], to [[succinylmonocholine]] and [[choline]]
| |
| | elimination_half-life =
| |
| | excretion = [[Kidney|Renal]] (10%)
| |
| | pregnancy_AU = A
| |
| | pregnancy_US = C
| |
| | legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| |
| | legal_UK = POM
| |
| | legal_US = Rx-only
| |
| | routes_of_administration = [[Intravenous therapy|Intravenous]]
| |
| }}
| |
|
| |
|
| {{CMG}}
| |
|
| |
|
| |
|
| |
| '''Suxamethonium chloride''' (also known as '''succinylcholine''', '''scoline''', or colloquially as '''sux''') is a medication widely used in [[emergency medicine]] and [[anesthesia]] to induce muscle relaxation, usually to make [[endotracheal intubation]] possible. Suxamethonium is sold under several [[trade name]]s such as '''Anectine''', and may be referred to as "sux" for short.
| |
|
| |
| Suxamethonium acts as a depolarizing [[neuromuscular-blocking drugs|neuromuscular blocker]]. It imitates the action of [[acetylcholine]] at the [[neuromuscular junction]], acting on [[muscle type nicotinic receptor]]s, but it is not degraded by [[acetylcholinesterase]] but by [[pseudocholinesterase]], a plasma cholinesterase. This hydrolysis by pseudocholinesterase is much slower than that of acetylcholine by acetylcholinesterase.
| |
|
| |
| ==Chemistry==
| |
| Suxamethonium is a white crystalline substance, it is odourless; solutions have a pH of about 4, the [[dihydrate]] melts about 160<sup>o</sup>C, the [[anhydrous]] melts at about 190<sup>o</sup>C; it is highly soluble in water (1 gram in about 1 mL), soluble in alcohol (1 gram in about 350 mL), slightly soluble in [[chloroform]], and practically insoluble in [[ether]]. Suxamethonium is a [[hygroscopic]] compound.<ref>Gennaro, Alfonso. Remington: The Science and Practice of Pharmacy, 20th ed. Lippincot, Wiliams and Wilkins, 2000:1336.</ref> The compound consists of two [[acetylcholine]] molecules that are linked by their [[acetyl]] groups.
| |
|
| |
| ==Effects==
| |
| There are two phases to the blocking effect of suxamethonium; phase 1 block and phase 2 block, of which the phase 2 block is the principal paralytic effect.
| |
|
| |
| ===Phase 1 block===
| |
| The first is due to the prolonged stimulation of the [[acetylcholine receptor]] results first in disorganized muscle contractions ([[fasciculation]]s, considered to be a side effect as mentioned below), as the acetylcholine receptors are stimulated. On stimulation, the acetylcholine receptor becomes a [[general ion channel]], resulting in a high flux of potassium out of the cell, and of sodium into the cell, generating an [[endplate potential]] less than the [[action potential]]. After this initial firing, the cell enters a [[refractory period]].
| |
|
| |
| ===Phase 2 block===
| |
| On continued stimulation, the acetylcholine receptors become [[desensitised]] and close. This means that new acetylcholine signals do not cause an action potential; and the continued binding of suxamethonium is ignored. This is the principal paralytic effect of suxamethonium, and wears off as the suxamethonium is degraded, and the acetylcholine receptors return to their normal configuration.
| |
|
| |
| ==Medical uses==
| |
| Its medical uses are limited to short-term muscle relaxation in anesthesia and intensive care, usually for facilitation of [[endotracheal intubation]]. Despite its many undesired effects on the circulatory system and skeletal muscles (including [[malignant hyperthermia]], a rare but life-threatening disease), it is perennially popular in emergency medicine because it arguably has the fastest onset and shortest duration of action of all muscle relaxants. Both are major points of consideration in the context of trauma care, where paralysis must be induced very quickly and the use of a longer-acting agent might mask the presence of a neurological deficit.
| |
|
| |
| Suxamethonium is quickly degraded by plasma [[cholinesterase]] and the duration of effect is usually in the range of a few minutes. When plasma levels of cholinesterase are greatly diminished or an atypical form of cholinesterase is present (an otherwise harmless inherited disorder), paralysis may last much longer.
| |
|
| |
| ==Side effects==
| |
| [[Adverse drug reaction|Side effect]]s include [[fasciculation]]s, muscle pains, acute [[rhabdomyolysis]] with [[hyperkalemia]], transient [[ocular hypertension]], [[constipation]]<ref>DiPiro, Joseph, et al. Pharmacotherapy: A Pathophysiologic Approach. 6th ed. McGraw-Hill, 2005:685.</ref> and changes in cardiac rhythm including [[bradycardia]], [[cardiac arrest]], and [[Ventricular fibrillation|ventricular dysrhythmia]]s. In children with unrecognized neuromuscular diseases, a single injection of suxamethonium can lead to massive release of potassium from skeletal muscles with cardiac arrest.
| |
|
| |
| Suxamethonium does not produce unconsciousness or anesthesia, and its effects may cause considerable psychological distress while simultaneously making it impossible for a patient to communicate. For these reasons, administration of the drug to a conscious patient is strongly contraindicated, except in necessary emergency situations.
| |
|
| |
| ===Hyperkalemia===
| |
| The side effect of [[hyperkalaemia]] is because the acetylcholine receptor is propped open, allowing continued flow of potassium ions into the [[extracellular fluid]]. A typical increase of potassium ion serum concentration on administration of suxamethonium is 0.5 mmol per litre, whereas the normal range of potassium is 3.5 to 5 mmol per litre, i.e. a significant increase.
| |
|
| |
| Hyperkalemia, in turn, results in other side-effects of [[ventricular fibrillation]] due to reduced to action potential initiation in the heart.
| |
|
| |
| ===Death===
| |
| This drug has occasionally been used as a paralyzing agent for executions by [[lethal injection]], although [[pancuronium bromide]] is the preferred agent today because of its longer duration of effect and its absence of fasciculations as a side effect. It has also allegedly been used for murder.<ref>{{cite web |url=http://i-mass.com/msmm0401.html |title=i-mass.com : international mass spectrometry web resource |accessdate=2007-08-14 |format= |work=}}</ref> For instance, suxamethonium is the drug that is suspected to have been used to murder Nevada State Controller [[Kathy Augustine]].<ref>{{cite news | url = http://news.rgj.com/apps/pbcs.dll/article?AID=2007703270354 | title = Chaz Higgs leaves jail | last = Bellisle | first = Martha | date = March 27, 2007 | accessdate = 2007-04-02 | publisher = [[Reno Gazette-Journal]]}}</ref>
| |
|
| |
| ==See also==
| |
| *[[Malignant hyperthermia]], a rare and fatal side effect of suxamethonium.
| |
| *[[Anesthetics]]
| |
|
| |
| ==References==
| |
| <references/>
| |